02553nam 2200565 450 991046485630332120200520144314.00-309-26940-7(CKB)3710000000103236(EBL)3564286(SSID)ssj0001119888(PQKBManifestationID)12436835(PQKBTitleCode)TC0001119888(PQKBWorkID)11150013(PQKB)11081283(MiAaPQ)EBC3564286(Au-PeEL)EBL3564286(CaPaEBR)ebr10863743(OCoLC)839275199(EXLCZ)99371000000010323620140127h20132013 uy| 0engurcnu||||||||txtccrCountering the problem of falsified and substandard drugs /Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National AcademiesWashington, District of Columbia :National Academies Press,[2013]©20131 online resource (375 p.)Description based upon print version of record.0-309-26939-3 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Acronyms and Abbreviations""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 The Effects of Falsified and Substandard Drugs""; ""3 The Magnitude of the Problem""; ""4 Causes of Falsified and Substandard Drugs""; ""5 Weaknesses in the Drug Distribution Chain""; ""6 Detection Technology""; ""7 An International Code of Practice for Falsified and Substandard Medicines""; ""Appendix A: Glossary""; ""Appendix B: Committee Biographies""; ""Appendix C: Meeting Agendas""Pharmaceutical industryQuality controlFraudPreventionElectronic books.Pharmaceutical industryQuality control.FraudPrevention.364.1668Buckley Gillian J.Gostin Lawrence O(Lawrence Ogalthorpe),Institute of Medicine.Board on Global Health,MiAaPQMiAaPQMiAaPQBOOK9910464856303321Countering the problem of falsified and substandard drugs2487220UNINA